TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $8,675,000 | +194.6% | 14,093 | -77.2% | 1.96% | +198.2% |
| Q4 2021 | $2,945,000 | -68.0% | 61,741 | -55.5% | 0.66% | -70.5% |
| Q3 2021 | $9,217,000 | -2.8% | 138,741 | +14.2% | 2.22% | -11.2% |
| Q2 2021 | $9,481,000 | +23.0% | 121,541 | +49.1% | 2.50% | +22.7% |
| Q1 2021 | $7,711,000 | -44.2% | 81,541 | -28.2% | 2.04% | -45.9% |
| Q4 2020 | $13,816,000 | +353.0% | 113,541 | +224.4% | 3.77% | +283.0% |
| Q3 2020 | $3,050,000 | +36.4% | 35,000 | 0.0% | 0.98% | +32.6% |
| Q2 2020 | $2,236,000 | +45.0% | 35,000 | 0.0% | 0.74% | +5.7% |
| Q1 2020 | $1,542,000 | -29.2% | 35,000 | 0.0% | 0.70% | -10.4% |
| Q4 2019 | $2,179,000 | – | 35,000 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |